Can you get medical cannabis for Tourette syndrome in the UK?

Tourette syndrome and other chronic tic disorders are among the conditions UK private specialists consider. The evidence is small but, unusually for this field, includes recent randomised trials — and the results are genuinely mixed rather than simply absent.

The short answer

  • Tourette syndrome is assessed by UK private specialists, usually in adults with severe tics.
  • No cannabis-based medicine is licensed in the UK for tic disorders.
  • Behavioural therapy comes first. Habit reversal and exposure therapy have the better evidence base.
  • Randomised crossover trials exist and show modest, inconsistent effects on tic severity.
  • Co-occurring OCD, ADHD and anxiety often drive as much of the burden as the tics themselves.

Is Tourette syndrome treated with medical cannabis in the UK?

It is assessed privately, typically in adults with severe tics that have not responded adequately to behavioural therapy and to the medicines normally used. There is no licensed cannabis-based medicine for tic disorders in the UK and no NHS route for this use.

UK practice puts behavioural treatment first: comprehensive behavioural intervention for tics, habit reversal training, or exposure and response prevention. These have the strongest evidence in Tourette syndrome and are recommended ahead of medication. Where medicines are used, they are usually antipsychotics such as aripiprazole or risperidone, or clonidine — all of which carry their own significant side effects, which is part of why alternatives get asked about.

Tourette syndrome rarely travels alone. Obsessive-compulsive symptoms, ADHD, anxiety and sleep problems are common, and often account for more of the day-to-day difficulty than the tics. A good assessment addresses those directly rather than treating them as background.

What the evidence actually shows

Tourette syndrome has better trial evidence than most conditions on this site, and the trials do not all point the same way. That is worth knowing before you read a clinic's summary of them.

A randomised double-blind crossover trial published in NEJM Evidence gave adults with severe Tourette syndrome six weeks of an oral oil containing THC and CBD and six weeks of placebo, separated by a washout, measuring total tic score on the Yale Global Tic Severity Scale. It found a reduction in tic severity during the active phase, alongside evidence of benefit for co-occurring obsessive-compulsive and anxiety symptoms. A separate large German trial of a THC:CBD spray in chronic tic disorders did not meet its primary endpoint.

The fair reading is: a real signal, small studies, inconsistent results, and no basis yet for treating this as established. Cannabidiol alone does not appear to be the active ingredient in tic reduction; where effects are seen, THC is involved, which brings the cognitive side effects with it.

The study behind that paragraph

Mosley PE, Webb L, Suraev A, et al. Tetrahydrocannabinol and cannabidiol in Tourette syndrome. NEJM Evidence. 2023;2(9). A double-blind randomised crossover trial in adults with severe Tourette syndrome comparing six weeks of oral THC:CBD oil with placebo, measured on the Yale Global Tic Severity Scale.

Read the paper →

What a specialist will want to see

There is no UK list of qualifying conditions, so nothing here entitles you to a prescription. A specialist works through your history and decides whether a monitored trial is justified for you. For Tourette syndrome they will typically look at:

The general requirements — age, a documented diagnosis, the convention that two standard treatments have been tried, and access to your medical records — are covered in What are the requirements?

Risks and reasons a specialist may say no

The main trade-off in Tourette syndrome is cognitive. THC can impair concentration and memory, which is a real cost for people who are working or studying — and often the same people whose tics are most disruptive.

Anxiety can worsen with THC in some people, which matters given how often anxiety accompanies Tourette syndrome. A personal or family history of psychosis weighs heavily against treatment. Because tics naturally wax and wane, and often improve from adolescence into adulthood, a specialist should build a review point into any trial rather than attributing every good period to the medicine.

If you want to take this further

The useful next step is a proper assessment, not a better list. Gather your diagnosis, the treatments you have already tried and what happened with each, and your current medicines — that is what a specialist needs in order to give you a straight answer.

The consultation itself, and what happens after it, is set out in What is the process to get a medical cannabis prescription? If Tourette syndrome is not the only thing you are being treated for, say so early: other conditions and other medicines change the assessment.

Frequently asked questions

Can I get medical cannabis for Tourette syndrome in the UK?

It is assessed by private specialists, usually in adults with severe tics where behavioural therapy and standard medicines have not helped enough. No cannabis-based medicine is licensed in the UK for tic disorders and there is no NHS route for this use.

Does the research show it works for tics?

The results are mixed. A randomised crossover trial in adults with severe Tourette syndrome found reduced tic severity with a THC:CBD oil compared with placebo, while a separate large trial of a THC:CBD spray did not meet its primary endpoint. The signal is real but not consistent, and the studies are small.

Should I try behavioural therapy first?

Yes. Behavioural treatments such as habit reversal training and exposure and response prevention have the strongest evidence in Tourette syndrome and are recommended ahead of medication. A specialist will want to know you have had proper access to them.

Is it considered for children with tics?

Prescribing for under-18s is unusual and is handled by paediatric specialists, not by adult private teleclinics. Flora House connects adults aged 18 and over. Tics also commonly improve from adolescence into adulthood, which affects how any treatment decision is weighed.

Sources and further reading

Every factual statement on this page is drawn from the following public sources. Links open in a new tab and are not affiliated with Flora House.

  1. Mosley PE, et al. Tetrahydrocannabinol and cannabidiol in Tourette syndrome. NEJM Evidence (2023)
  2. NHS: Tourette's syndrome
  3. Tourettes Action: Treatment and support
  4. NICE guideline NG144: Cannabis-based medicinal products
  5. NHS: Medical cannabis (and cannabis oils)
  6. House of Commons Library briefing CBP-8355: Medical use of cannabis
  7. MHRA: The supply, manufacture, importation and distribution of unlicensed cannabis-based products for medicinal use

Patient guide · Written by the Flora House editorial team · Last reviewed: 31 August 2026